Insider Trading June 24, 2026 09:37 PM

Carlyle Credit Income Fund Executive Purchases Shares Amid Price Decline

Joseph Nelson acquires 2,000 shares as CCIF trades near 52-week lows despite high dividend yield

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
CCIF

Joseph Nelson, serving as Principal Financial Officer, Principal Accounting Officer, and Treasurer at Carlyle Credit Income Fund (NASDAQ: CCIF), executed a share purchase on June 22, 2026. The transaction involved 2,000 shares at $2.73 each, bringing Nelson’s direct holdings to 5,700 shares. The buy occurs as the fund’s stock trades close to its 52-week low of $2.57, following a 34% decline over the past six months. Despite the price drop, CCIF maintains a dividend yield of 26.47% according to InvestingPro data. Recent disclosures include an unaudited net asset value per common share of $3.54 as of May 31, 2026, filed via Form 8-K with the SEC. The fund, incorporated in Delaware and headquartered in New York, lists both common and preferred shares on the New York Stock Exchange.

Carlyle Credit Income Fund Executive Purchases Shares Amid Price Decline
CCIF
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Joseph Nelson, a senior executive at Carlyle Credit Income Fund, purchased 2,000 shares at $2.73 per share on June 22, 2026, increasing his direct holdings to 5,700 shares.
  • CCIF’s stock trades near its 52-week low of $2.57, following a 34% decline over the past six months, while maintaining a high dividend yield of 26.47%.
  • The fund reported an unaudited net asset value per common share of $3.54 as of May 31, 2026, via a Form 8-K filing with the SEC, with no additional operational updates provided.

Joseph Nelson, holding the roles of Principal Financial Officer, Principal Accounting Officer, and Treasurer at Carlyle Credit Income Fund (NASDAQ: CCIF), completed a purchase of the company’s common stock on June 22, 2026. The transaction details indicate that 2,000 shares were acquired at a price of $2.73 per share, resulting in a total value of $5,460. Following this acquisition, Nelson’s direct ownership in Carlyle Credit Income Fund common stock stands at 5,700 shares.

The insider purchase takes place as CCIF trades near its 52-week low of $2.57. The stock has experienced a 34% decline over the past six months. Despite the downward price movement, the fund offers a dividend yield of 26.47%, according to data provided by InvestingPro. Additional insights from InvestingPro Tips suggest the stock is in oversold territory, with six further tips available to subscribers. For more in-depth analysis, investors can access CCIF’s comprehensive Pro Research Report, which is available for this equity and over 1,400 other US equities.

In recent corporate disclosures, Carlyle Credit Income Fund reported an unaudited net asset value per common share of $3.54 as of May 31, 2026. This information was communicated through a press release statement included in the company’s Form 8-K filing with the U.S. Securities and Exchange Commission. The announcement was made public without additional financial or operational updates beyond the net asset value figure. Carlyle Credit Income Fund is incorporated in Delaware and maintains its headquarters in New York. The company lists both its common shares and preferred shares on the New York Stock Exchange. These disclosures provide investors with the latest available financial information regarding the company’s net asset value.

Risks

  • The stock’s proximity to its 52-week low and recent 34% decline may indicate continued downward pressure, though the article does not specify causes.
  • Limited operational updates in recent disclosures may leave investors with less visibility into the fund’s current financial health beyond net asset value.
  • High dividend yields can sometimes signal market concerns about future earnings sustainability, though this is not explicitly stated in the provided text.

More from Insider Trading

Executive Capital Commitment at Bed Bath & Beyond Aug 6, 2026 EXLService President Vikas Bhalla Executes $384,890 Share Sale Under Pre-Existing Trading Plan Aug 6, 2026 Arcutis Biotherapeutics Executive Divests Shares Amid Strong Financial Backdrop Aug 6, 2026 Executive Capital Deployment and Leadership Restructuring at Hanover Bancorp Aug 3, 2026 Adaptive Biotechnologies Executive Liquidates Shares as Volume Metrics Diverge From Profitability Aug 3, 2026